Drug Registration under the new rules companies how to change-.docVIP

 PAGE \* MERGEFORMAT 10 Drug Registration under the new rules companies how to change? Pain after the broken cocoon butterfly Any change in the old situation, there will be pain, first after the legislation is to break through the ages opponents are. Pharmaceutical market reform is doomed from October 1, 2007 onwards the new millennium. Before the implementation of the GSP, pharmaceutical commercial companies Longshehunza unsightly situation now presented is a benign and orderly development; before the implementation of the GMP, pharmaceutical manufacturing Lieyao not interfere with counterfeit medicine all the time, and now the safety of drugs has been to ensure a large extent. The face of the world’s top 500 pharmaceutical companies worldwide sales of up to one another a multi-billion dollar blockbuster in the new ‘drug registration management methods’ before the implementation of most of us indulge in a small security that the blessing of self-deception of the world. Lu Xun’s ‘take-ism’ by the majority of domestic pharmaceutical enterprises regarded as a business of canon that, however pure, metaphysical ‘take-ism’ Querang great country into the mud of the pharmaceutical industry. Indeed, the new ‘approach’ the implementation of the R amp;amp; D capabilities that do not, there is no research funding, generic drug based solely on the pharmaceutical companies is undoubtedly a negative situation, but in terms of the entire Chinese pharmaceutical industry is a big positive, research and development perfect platform for medium and large pharmaceutical companies, or have certain characteristics of the pharmaceutical companies will themselves, and at the national macro-policies under the guidance of innovation, imitation is the direction of creating a large country is bound to unstoppable rise of medicine. Innovation to improve the level of innovation to broaden access The new ‘approach’ the matter before the implementation of the large number of China’s drug